What is Testolone (RAD140)?
Testolone (RAD140) is a selective androgen receptor modulator (SARM) being developed by the pharmaceutical company Radius. Testolone is very new to the commercial market with its initial discovery in 2010. The initial studies, company reports, and anecdotal user reviews have been highly promising for the muscle building properties of RAD 140. (RAD-140), has a ratio of anabolic to androgenic as much as 90:1 compared to testosterone, which has a ratio of 1:1
Benefits of RAD 140
Increased Muscle Mass
Many severe diseases like cancer and AIDs cause muscle wasting (loss of muscle tissue), fatigue, and weakness. The muscle building role of Testolone can help reverse this problem and increase muscle gain. Because of its selectivity, RAD 140 improves weight in patients with prostate cancer because it doesn’t stimulate an increase in prostate growth like testosterone does.
Testolone mimics the positive effects of testosterone without the side effects.
Fat loss
It is very common for users supplementing with RAD140 to report significant fat loss.
Testolone directly increases fat oxidation but also indirectly decreases fat tissue by increasing muscle, making it favorable for patients looking to lose weight without sacrificing muscle mass. Having higher levels of muscle mass will also increase metabolism and further promote fat loss.
Dosages of RAD-140
The recommended dosage of RAD140 is 10-20mg/day.
The half-life of RAD-140 should be 12-18 hours. Thus, a once a day dosage.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Medical disclaimer: This information is for educational and informational purposes only and may not be construed as medical advice. The information is not intended to replace medical advice offered by physicians. These products are sold for research purposes only and not intended to be used by consumers for any other purposes whatsoever.
top of page
$1.00Price
bottom of page